Biological heterogeneity in ADNI amnestic mild cognitive impairment

Alzheimer's Disease Neuroimaging Initiative

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

BACKGROUND: Previous work examining normal controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI) identified substantial biological heterogeneity. We hypothesized that ADNI mild cognitive impairment (MCI) subjects would also exhibit heterogeneity with possible clinical implications.

METHODS: ADNI subjects diagnosed with amnestic MCI (n=138) were clustered based on baseline magnetic resonance imaging, cerebrospinal fluid, and serum biomarkers. The clusters were compared with respect to longitudinal atrophy, cognitive trajectory, and time to conversion.

RESULTS: Four clusters emerged with distinct biomarker patterns: The first cluster was biologically similar to normal controls and rarely converted to Alzheimer's disease (AD) during follow-up. The second cluster had characteristics of early Alzheimer's pathology. The third cluster showed the most severe atrophy but barely abnormal tau levels and a substantial proportion converted to clinical AD. The fourth cluster appeared to be pre-AD and nearly all converted to AD.

CONCLUSIONS: Subjects with MCI who were clinically similar showed substantial heterogeneity in biomarkers.

Original languageEnglish (US)
Pages (from-to)511-521
Number of pages11
JournalAlzheimer's & dementia : the journal of the Alzheimer's Association
Volume10
Issue number5
DOIs
StatePublished - Sep 1 2014

Fingerprint

Neuroimaging
Alzheimer Disease
Biomarkers
Atrophy
Cognitive Dysfunction
Cerebrospinal Fluid
Magnetic Resonance Imaging
Pathology
Serum

Keywords

  • ADNI
  • Alzheimer's disease
  • Amnestic MCI
  • Clustering
  • Heterogeneity

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Geriatrics and Gerontology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Biological heterogeneity in ADNI amnestic mild cognitive impairment. / Alzheimer's Disease Neuroimaging Initiative.

In: Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 10, No. 5, 01.09.2014, p. 511-521.

Research output: Contribution to journalArticle

Alzheimer's Disease Neuroimaging Initiative. / Biological heterogeneity in ADNI amnestic mild cognitive impairment. In: Alzheimer's & dementia : the journal of the Alzheimer's Association. 2014 ; Vol. 10, No. 5. pp. 511-521.
@article{42ac67f3fbec4676b3387c0e2c37ce54,
title = "Biological heterogeneity in ADNI amnestic mild cognitive impairment",
abstract = "BACKGROUND: Previous work examining normal controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI) identified substantial biological heterogeneity. We hypothesized that ADNI mild cognitive impairment (MCI) subjects would also exhibit heterogeneity with possible clinical implications.METHODS: ADNI subjects diagnosed with amnestic MCI (n=138) were clustered based on baseline magnetic resonance imaging, cerebrospinal fluid, and serum biomarkers. The clusters were compared with respect to longitudinal atrophy, cognitive trajectory, and time to conversion.RESULTS: Four clusters emerged with distinct biomarker patterns: The first cluster was biologically similar to normal controls and rarely converted to Alzheimer's disease (AD) during follow-up. The second cluster had characteristics of early Alzheimer's pathology. The third cluster showed the most severe atrophy but barely abnormal tau levels and a substantial proportion converted to clinical AD. The fourth cluster appeared to be pre-AD and nearly all converted to AD.CONCLUSIONS: Subjects with MCI who were clinically similar showed substantial heterogeneity in biomarkers.",
keywords = "ADNI, Alzheimer's disease, Amnestic MCI, Clustering, Heterogeneity",
author = "{Alzheimer's Disease Neuroimaging Initiative} and Jasmine Nettiksimmons and Charles DeCarli and Susan Landau and Beckett, {Laurel A}",
year = "2014",
month = "9",
day = "1",
doi = "10.1016/j.jalz.2013.09.003",
language = "English (US)",
volume = "10",
pages = "511--521",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Biological heterogeneity in ADNI amnestic mild cognitive impairment

AU - Alzheimer's Disease Neuroimaging Initiative

AU - Nettiksimmons, Jasmine

AU - DeCarli, Charles

AU - Landau, Susan

AU - Beckett, Laurel A

PY - 2014/9/1

Y1 - 2014/9/1

N2 - BACKGROUND: Previous work examining normal controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI) identified substantial biological heterogeneity. We hypothesized that ADNI mild cognitive impairment (MCI) subjects would also exhibit heterogeneity with possible clinical implications.METHODS: ADNI subjects diagnosed with amnestic MCI (n=138) were clustered based on baseline magnetic resonance imaging, cerebrospinal fluid, and serum biomarkers. The clusters were compared with respect to longitudinal atrophy, cognitive trajectory, and time to conversion.RESULTS: Four clusters emerged with distinct biomarker patterns: The first cluster was biologically similar to normal controls and rarely converted to Alzheimer's disease (AD) during follow-up. The second cluster had characteristics of early Alzheimer's pathology. The third cluster showed the most severe atrophy but barely abnormal tau levels and a substantial proportion converted to clinical AD. The fourth cluster appeared to be pre-AD and nearly all converted to AD.CONCLUSIONS: Subjects with MCI who were clinically similar showed substantial heterogeneity in biomarkers.

AB - BACKGROUND: Previous work examining normal controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI) identified substantial biological heterogeneity. We hypothesized that ADNI mild cognitive impairment (MCI) subjects would also exhibit heterogeneity with possible clinical implications.METHODS: ADNI subjects diagnosed with amnestic MCI (n=138) were clustered based on baseline magnetic resonance imaging, cerebrospinal fluid, and serum biomarkers. The clusters were compared with respect to longitudinal atrophy, cognitive trajectory, and time to conversion.RESULTS: Four clusters emerged with distinct biomarker patterns: The first cluster was biologically similar to normal controls and rarely converted to Alzheimer's disease (AD) during follow-up. The second cluster had characteristics of early Alzheimer's pathology. The third cluster showed the most severe atrophy but barely abnormal tau levels and a substantial proportion converted to clinical AD. The fourth cluster appeared to be pre-AD and nearly all converted to AD.CONCLUSIONS: Subjects with MCI who were clinically similar showed substantial heterogeneity in biomarkers.

KW - ADNI

KW - Alzheimer's disease

KW - Amnestic MCI

KW - Clustering

KW - Heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=84908877296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908877296&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2013.09.003

DO - 10.1016/j.jalz.2013.09.003

M3 - Article

C2 - 24418061

AN - SCOPUS:84908877296

VL - 10

SP - 511

EP - 521

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 5

ER -